Preventive Effect and Mechanism of Compound Danshen Dripping Pills on Contrast-induced Nephropathy After Percutaneous Coronary Interventional

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2023 Dec 21

PMID 38124888

Authors

Han Fu

Linrui Wang

Shuo Ying

Zhicheng Zhao

Peng Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Contrast-induced nephropathy (CIN) is one of the most common complications after coronary stent implantation due to the extensive development of coronary catheterization technology. Compound Danshen dripping pills (CDDP) are clinically used as cardiovascular drugs, relieving systemic inflammatory response. Previous studies have observed that CDDP can decrease CIN incidence after coronary stent implantation with uncertain effectiveness.

Methods: We conducted a prospective, randomized, single-center, single-blind, controlled trial. We enrolled patients 18 years and older with unstable angina pectoris and NSTEMI who underwent PCI at the Tianjin Chest Hospital between November 1, 2021, and November 31, 2022, and followed for 30 days. Patients were randomized to CDDP and hydration therapy (10 capsules three times/day; = 411) or hydration only ( = 411). The primary outcome was the contrast nephropathy incidence, defined as an elevation in serum creatinine by more than 25% or 44 μmol/L from baseline within 48-72 h of contrast exposure. Secondary outcomes included major adverse cardiovascular events post-surgery and during follow-up.

Results: After 48 h of operation, the two groups had statistical significance in Scr and BUN values (80.0 ± 12.59 vs. 84.43 ± 13.49, < 0.05; 6.22 ± 1.01 vs. 6.40 ± 0.93, < 0.05). The difference in Scr in 72 h between the two groups was statistically significant (76.42 ± 10.92 vs. 79.06 ± 11.58, < 0.05). The CIN incidence was significantly lower in the CDDP group than in the hydration group. The CIN risk was significantly elevated in patients with LVEF <50%, contrast volume ≥160 ml, and hypertension, after 48 and 72 h of operation. The serum inflammation index levels NGAL, TNF-α, oxidative stress indexes SOD, and MDA significantly differed between the two groups. However, there was no significant difference in serum apoptosis indexes Bax, Bcl-2, and Casepase-9.

Conclusions: CDDP pre-treatment could prevent contrast-induced nephropathy. Inflammatory response and oxidative stress could be significant in the CDDP mechanism.

References

Bonventre J, Weinberg J . Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003; 14(8):2199-210. DOI: 10.1097/01.asn.0000079785.13922.f6. View

Zhang P, Zhang X, Zhang J, Song Y, Liu T, Zeng Z . Novel Nanoliposomes Alleviate Contrast-Induced Nephropathy by Mediating Apoptosis Response in New Zealand Rabbits. Front Mol Biosci. 2021; 8:681849. PMC: 8290201. DOI: 10.3389/fmolb.2021.681849. View

Shen S, Hu Z, Li Q, Wang S, Song C, Wu D . Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease. Nephrology (Carlton). 2014; 19(3):129-35. DOI: 10.1111/nep.12203. View

Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J . Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification. Int J Clin Exp Pathol. 2014; 7(10):7172-81. PMC: 4230115. View

Lv L, Yuan X, Jiang L . Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022; 101(8):e28994. PMC: 8878783. DOI: 10.1097/MD.0000000000028994. View

Zorov D, Juhaszova M, Sollott S . Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014; 94(3):909-50. PMC: 4101632. DOI: 10.1152/physrev.00026.2013. View

Zou H, Zhang B, Xu X, Su J, Sun Y, Xue S . Urinary metabolomic strategy to evaluate Compound Danshen Dripping Pills for myocardial ischaemia in rats. J Pharm Biomed Anal. 2015; 112:98-105. DOI: 10.1016/j.jpba.2015.04.033. View

McMaster W, Kirabo A, Madhur M, Harrison D . Inflammation, immunity, and hypertensive end-organ damage. Circ Res. 2015; 116(6):1022-33. PMC: 4535695. DOI: 10.1161/CIRCRESAHA.116.303697. View

Yan S, Zhang X, Zheng H, Hu D, Zhang Y, Guan Q . Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH oxidase-dependent IκB kinase/NF-κB pathway. Free Radic Biol Med. 2014; 78:190-201. DOI: 10.1016/j.freeradbiomed.2014.11.004. View

10.

Mamoulakis C, Fragkiadoulaki I, Karkala P, Georgiadis G, Zisis I, Stivaktakis P . Contrast-induced nephropathy in an animal model: Evaluation of novel biomarkers in blood and tissue samples. Toxicol Rep. 2019; 6:395-400. PMC: 6506864. DOI: 10.1016/j.toxrep.2019.04.007. View

11.

Hamasaki S, Tei C . Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. J Cardiol. 2011; 57(3):231-8. DOI: 10.1016/j.jjcc.2011.02.003. View

12.

Mehran R, Nikolsky E . Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006; (100):S11-5. DOI: 10.1038/sj.ki.5000368. View

13.

Tsamouri M, Rapti M, Kouka P, Nepka C, Tsarouhas K, Soumelidis A . Histopathological evaluation and redox assessment in blood and kidney tissues in a rabbit contrast-induced nephrotoxicity model. Food Chem Toxicol. 2017; 108(Pt A):186-193. DOI: 10.1016/j.fct.2017.07.058. View

14.

Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A . Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008; 52(3):595-605. DOI: 10.1053/j.ajkd.2008.01.020. View

15.

Nijssen E, Rennenberg R, Nelemans P, Essers B, Janssen M, Vermeeren M . Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017; 389(10076):1312-1322. DOI: 10.1016/S0140-6736(17)30057-0. View

16.

Fang D, Wang Y, Zhang Z, Yang D, Gu D, He B . Calorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation. Oxid Med Cell Longev. 2021; 2021:2999296. PMC: 8548166. DOI: 10.1155/2021/2999296. View

17.

Guo J, Yong Y, Aa J, Cao B, Sun R, Yu X . Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia. Sci Rep. 2016; 6:37919. PMC: 5131350. DOI: 10.1038/srep37919. View

18.

Iordache A, Docea A, Buga A, Zlatian O, Ciurea M, Rogoveanu O . Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model. Food Chem Toxicol. 2019; 135:111038. DOI: 10.1016/j.fct.2019.111038. View

19.

Topal I, Ozdamar M, Catakli T, Malkoc I, Hacimuftuoglu A, Mamoulakis C . Renoprotective Effect of Taxifolin in Paracetamol-Induced Nephrotoxicity: Emerging Evidence from an Animal Model. J Clin Med. 2023; 12(3). PMC: 9917797. DOI: 10.3390/jcm12030876. View

20.

Cuddy E, Robertson S, Cross S, Isles C . Risks of coronary angiography. Lancet. 2005; 366(9499):1825. DOI: 10.1016/S0140-6736(05)67729-X. View